ADAM are a step closer to 3D bioprinting organic bone implants

ADAM (CT, USA) have passed the regulatory requirements needed to start preclinical trials later this month with their 3D bioprinting technology that prints organic bone structures. ADAM (CT, USA) have passed the regulatory requirements needed to start preclinical trials later this month with their 3D bioprinting technology that prints organic bone structures. The innovative bioprinting technique uses a combination of novel materials in the printing process. The researchers at ADAM have modified the biopolymer polycaprolactone to include hydroxyapatite, which has increased its strength and bioresorbability. These attributes make the biopolymer suitable to print implants for treating defects on tubular bones...